Preferred Developer Status

CareCapital Group plc
17 January 2008


Embargoed: for release at 07.00, 17 January 2008




                              CareCapital Group Plc
                                 ("CareCapital")


                  Investment and Development Programme in the UK


                      Successful bid on two Medical Centres


CareCapital, the AIM listed healthcare real estate company, announces that it
has been selected as the preferred developer for the provision of a £4.1 million
new build medical centre in Heswall and a new medical centre in West Wirral
exceeding £5 million.

The 1,556 sq metre Heswall project will accommodate six GPs together with a
range of support services. The current development programme anticipates
construction starting before the end of 2008 with the new facility becoming
operational in December 2009.

The 2,241 sq metre West Wirral development will house a ten GP Practice and
ancillary medical facilities. The development programme is on a similar timeline
to the Heswall project.

Paul Stacey, Chief Executive of CareCapital commented: "It is very pleasing to
have been selected as preferred developer on these two exciting projects. We are
looking forward to working with all the stakeholders, including the Doctors and
the Primary Care Trust, to bring the developments to fruition in the shortest
possible timespan. These projects further strengthen our current business
pipeline; as the Company continues to expand its investment and development
programme in both the UK and Germany."


                                     -ends-



For further information please visit www.carecapital.co.uk or contact:

Paul Stacey, Managing Director   Lindsay Mair, Director             Simon Hudson,
Shareen Courtney, Marketing      - Corporate Finance                Paul Youens, Paul Young  
                          
CareCapital Group Plc            Daniel Stewart & Co. Plc           Tavistock Communications

Tel: [phone]               Tel: [phone]                 Tel: [phone]
                                                                    or 07966 477256

[e-mail]        [e-mail]   [e-mail]
[e-mail]                                         [e-mail]
                                                                    [e-mail]







                      This information is provided by RNS
            The company news service from the London Stock Exchange